Not applicableUnknownNCT03670576What this trial is testingIt's Not JUST Idiopathic Pulmonary Fibrosis StudyWho this might be right forInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis University of Nottingham 250
Large-scale testing (Phase 3)Study completedNCT00662038What this trial is testingOpen-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Genentech, Inc. 1,058
Large-scale testing (Phase 3)Ended earlyNCT04419558What this trial is testingZephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Kyntra Bio 372
Large-scale testing (Phase 3)Active Not RecruitingNCT06238622What this trial is testingA Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastWho this might be right forIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis Boehringer Ingelheim 1,666
Not applicableLooking for participantsNCT03478553What this trial is testingThe Genetics of Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis (IPF) University of Colorado, Denver 1,000
Not applicableUnknownNCT05449431What this trial is testingComparison of the 1-min Sit-to-Stand Test to the 6-minute Walk Test in the Respiratory Functional Assessment of Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Fondation Hôpital Saint-Joseph 36
Not applicableNot Yet RecruitingNCT07728448What this trial is testingPredictors of Pulmonary Embolism in Interstitial Lung Disease With Worsening SymptomsWho this might be right forPulmonary EmbolismInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis+1 more Assiut University 70
Not applicableStudy completedNCT04430491What this trial is testingTo Evaluate the Use of Radiomics to Classify Between Idiopathic Pulmonary Fibrosis and Interstitial Lung DiseaseWho this might be right forInterstitial Lung DiseaseIdiopathic Pulmonary FibrosisUsual Interstitial Pneumonia Maastricht University 300
Testing effectiveness (Phase 2)Study completedNCT02085018What this trial is testingPilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Newcastle-upon-Tyne Hospitals NHS Trust 45
Not applicableUnknownNCT04619199What this trial is testingInfluence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisPulmonary DiseasePulmonary Medicine Assistance Publique - Hôpitaux de Paris 200
Testing effectiveness (Phase 2)Study completedNCT02048644What this trial is testingEffect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis Hull University Teaching Hospitals NHS Trust 20
Post-approval studies (Phase 4)Study completedNCT02598193What this trial is testingSafety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Hoffmann-La Roche 89
Testing effectiveness (Phase 2)Active Not RecruitingNCT05389215What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPFWho this might be right forIdiopathic Pulmonary Fibrosis Daewoong Pharmaceutical Co. LTD. 102
Not applicableApproved For MarketingNCT02141087What this trial is testingExpanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to PirfenidoneWho this might be right forIdiopathic Pulmonary Fibrosis Genentech, Inc.
Not applicableStudy completedNCT00815711What this trial is testingIdiopathic Pulmonary Fibrosis Registry for Future StudiesWho this might be right forLung Disease, InterstitialIdiopathic Pulmonary Fibrosis Ohio State University 13
Testing effectiveness (Phase 2)Study completedNCT00063869What this trial is testingStudy Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisWho this might be right forPulmonary Fibrosis Wyeth is now a wholly owned subsidiary of Pfizer 88
Not applicableUnknownNCT06445686What this trial is testingOngoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.Who this might be right forIdiopathic Pulmonary Fibrosis Biosency 30
Large-scale testing (Phase 3)Study completedNCT01335477What this trial is testingSafety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients IIWho this might be right forPulmonary Fibrosis Boehringer Ingelheim 551
Very early researchActive Not RecruitingNCT05365802What this trial is testingFAPI PET for Lung FibrosisWho this might be right forInterstitial Lung DiseaseIdiopathic Interstitial PneumoniasDrug-Induced Pneumonitis+4 more University of California, Los Angeles 30
Testing effectiveness (Phase 2)Looking for participantsNCT07572383What this trial is testingAdvanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisWho this might be right forInterstitial Lung DiseasePulmonary Fibrosis Peter Caravan 15